» Articles » PMID: 38642270

Leukocytospermia Does Not Negatively Impact Outcomes in in Vitro Fertilization Cycles with Intracytoplasmic Sperm Injection and Preimplantation Genetic Testing for Aneuploidy: Findings from 5435 Cycles

Overview
Publisher Springer
Date 2024 Apr 20
PMID 38642270
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate whether leukocytospermia (defined as the presence of ≥ 1 × 10 white blood cells/mL) affects clinical and embryologic outcomes in in vitro fertilization (IVF) cycles with intracytoplasmic sperm injection (ICSI) and preimplantation genetic testing for aneuploidy (PGT-A).

Methods: This was a retrospective cohort study including 5425 cycles between January 2012 to December 2021 at a single large university-affiliated fertility clinic. The primary outcome was live birth rate (LBR).

Results: The prevalence of leukocytospermia was 33.9% (n = 1843). Baseline characteristics including female age, BMI, AMH, Day 3 FSH, and male partner's age were similar in cycles with and without leukocytospermia. The LBR after the first euploid embryo transfer was similar in those with and without leukocytospermia (62.3% vs. 63% p = 0.625). Secondary outcomes including clinical pregnancy rate (CPR), sustained implantation rate (SIR), fertilization (2PN) rate, blastulation rate, and aneuploidy rate were also evaluated. The CPR (73.3% vs 74.9%, p = 0.213) and SIR (64.6% vs. 66%, p = 0.305) were similar in both groups. The 2PN rate was also similar in both groups (85.7% vs. 85.8%, p = 0.791), as was the blastulation rate per 2PN (56.7% vs. 57.5%, p = 0.116). The aneuploidy rate was not significantly different between groups (25.7% vs 24.4%, p = 0.053). A generalized estimation equation with logistic regression demonstrated that the presence leukocytospermia did not influence the LBR (adjusted OR 0.878; 95% CI, 0.680-1.138).

Conclusion: Leukocytospermia diagnosed just prior to an IVF cycle with PGT-A does not negatively impact clinical or embryologic outcomes.

References
1.
HELLER C, Clermont Y . Spermatogenesis in man: an estimate of its duration. Science. 1963; 140(3563):184-6. DOI: 10.1126/science.140.3563.184. View

2.
Velez D, Ohlander S, Niederberger C . Pyospermia: background and controversies. F S Rep. 2021; 2(1):2-6. PMC: 8244362. DOI: 10.1016/j.xfre.2021.01.001. View

3.
Yilmaz S, Koyuturk M, Kilic G, Alpak O, Aytoz A . Effects of leucocytospermia on semen parameters and outcomes of intracytoplasmic sperm injection. Int J Androl. 2005; 28(6):337-42. DOI: 10.1111/j.1365-2605.2005.00562.x. View

4.
Qiao X, Zeng R, Yang Z, Xu L, Ma Q, Yang Y . Effects of leukocytospermia on the outcomes of assisted reproductive technology. Andrologia. 2022; 54(6):e14403. PMC: 9542176. DOI: 10.1111/and.14403. View

5.
Fu W, Cui Q, Yang Z, Bu Z, Shi H, Bi B . High sperm DNA fragmentation increased embryo aneuploidy rate in patients undergoing preimplantation genetic testing. Reprod Biomed Online. 2023; 47(6):103366. DOI: 10.1016/j.rbmo.2023.103366. View